This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Stem Cell Orthopedic
Stem Cell Orthopedic Weighs in on Misinformation Within Controversial Performance Enhancing Drug Debate
(PRWEB) March 16, 2013
StemCellOrthopedic.com, popular website of the Institute of Regenerative and Molecular Orthopaedics (IRMO), world renowned stem cell therapy experts, have recently written a blog tackling misinformation contained in the greater debate regarding the controversial use of performance enhancing drugs (PED) by professional athletes. In particular, Stem Cell Orthopedics challenges the popular fallacy that the use of IGF-1 is necessarily indicative of PED abuse. This article comes as good news to the millions of pain sufferers around the world, who can benefit from substances like IGF-1 and its ability to enhance the body’s ability to repair injuries.
As the controversy involving PEDs intensifies, especially with increased media exposure due to the recent disgrace of cyclist Lance Armstrong, misinformation and half-truths have become commonplace. Even the medical community itself has been caught up in the wake of this controversy, by mislabeling substances such as IGF-1, a cytokine, as a growth hormone. Stem Cell Orthopedics recognizes this misunderstanding as potentially dangerous, especially if these important repair enhancers become overly regulated or banned completely as a result of this widespread ignorance.
The blog explains in detail the power of IGF-1, other cytokines, and stem cell medicine to help profoundly effect and increase the speed of healing in the body. The blog continues to illuminate the natural prevalence of IGF-1 in red meat and in platelet rich plasma therapy (PRP), the highly effective and innovative treatment used by experts throughout the sport medicine world. Stem Cell Orthopedics is determined to help set the record straight on the many invaluable applications of cytokines, including IGF-1, TGF, and FGF, on tissue repair in the sports world and beyond.
Headed by the world-renowned stem cell treatment pioneer, Dr. Joseph Purita, Stem Cell Orthopedic is committed to offering state-of-the-art stem cell and PRP therapy to patients around the world. They are one of only a few orthopedic practices on earth that combine stem cell therapy and PRP injections with orthopedic surgery to exponentially enhance patient’s ability to heal and recover. This latest blog dispelling the myths behind IGF-1 is part of Stem Cell Orthopedic’s ongoing effort to advance the stem cell industry, to improve the lives of potentially millions of pain sufferers throughout the world.
About Stem Cell Orthopedic
The Institute of Regenerative and Molecular Orthopaedics (IRMO) is a world-class orthopedic practice and stem cell facility staffed with seasoned board certified orthopedic surgeons. They differ from most orthopedic practices because they offer stem cells and platelet rich plasma (PRP) therapy in conjunction with surgery or as alternative to surgical procedures. They utilize state-of-the-art technology and the latest in stem cell research to best treat their patients. IRMO uses hematopoietic stem cells (HSC), which are found circulating in blood, fat, and bone marrow, to help repair the body. They are headed by Medical Director, Dr. Joseph Purita, a world-renowned pioneer in laser orthopedic surgery and graduate of the esteemed Georgetown University Medical School. For more information, visit http://www.stemcellorthopedic.com/ or follow them on Facebook or Twitter.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/3/prweb10506457.htm